Market Insights

BOURSSOLE Newsroom

Stay ahead of the market with our curated AI-powered financial news and expert analysis.

3 results for “Moroccan Pharma”
Promopharm Q1 2026 Revenue Slides 1.9% to DH208.2m Amid Hospital Sales Dip
Stocks Market
•June 1st, 2026

Promopharm Q1 2026 Revenue Slides 1.9% to DH208.2m Amid Hospital Sales Dip

Promopharm’s first‑quarter 2026 turnover fell to DH208.2 million, a 1.9 % dip from the same period last year, primarily driven by weaker hospital‑segment sales. Despite the slight decline, the firm kept commercial momentum alive with successful new‑product launches, trimmed its total debt to DH182 m...

Read More
You've reached the end of the list